Related Experiment Video
Updated: May 12, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
A Framework for Locally Imputing and Predicting Biomarker Trajectories Under Irregular Monitoring: Application to
Felipe Montano-Campos1, Patrick Heagerty2, Eric Haupt3
1University of Southern California.
This study presents a new framework for handling irregular biomarker data, improving predictions for chronic myeloid leukemia monitoring. The method ensures accurate forecasting even with missing patient data, enhancing clinical utility.
Area of Science:
- Biomedical data science
- Clinical informatics
- Longitudinal data analysis
Background:
- Irregular patient monitoring and missing data hinder the use of longitudinal biomarkers in clinical practice.
- Accurate tracking of biomarker trajectories is crucial for effective disease management, particularly in conditions like chronic myeloid leukemia (CML).
Purpose of the Study:
- To develop a generalizable framework for creating complete biomarker trajectories and forecasting future values from irregularly collected data.
- To enhance the utility of longitudinal biomarkers in real-world clinical settings by addressing data gaps.
Main Methods:
- Developed a framework combining interval-aligned preprocessing, localized multiple imputation, and machine learning (RNN, XGBoost) for forecasting.
- Applied the method to BCR::ABL1 monitoring data in CML, aligning measurements to 90-day intervals.
- Utilized a windowed, uncertainty-propagating imputation strategy and trained models to predict values 3 and 6 months ahead.
Main Results:
- Achieved low Root Mean Square Errors (RMSEs) of 1.22-1.24 for 3-month BCR::ABL1 predictions, below observed variability.
- Maintained prediction accuracy even when the most recent patient visit data was excluded, simulating extended follow-up.
- Demonstrated the framework's ability to preserve local temporal structure and support individualized monitoring.
Conclusions:
- The proposed framework effectively generates complete biomarker trajectories and enables accurate future value prediction from irregular data.
- This approach enhances the reliability and utility of longitudinal biomarkers in routine clinical practice for diseases like CML.
- The framework is adaptable to other continuous biomarkers measured under real-world, non-ideal schedules.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025